Skip to main content

Biotechnology

Lincoln Property Company Breaks Ground on Waltham Life Science Building

Published 8/6/2020

Lincoln Property Company broke ground in July of 2020 on a 140,000-sf life science building in Waltham, Mass. Designed by DiMella Shaffer in collaboration with AHA Consulting Engineers, the four-story structure will offer 35,000 sf of flexible and customizable office and laboratory space on each floor. A robust mechanical penthouse will support the installation of sophisticated infrastructure, and highly resilient energy and telecommunications services will be ensured by an onsite emergency power supply.

Read More

Cell and Gene Therapy Catapult Plans COVID-19 Vaccine Production Center

Published 8/5/2020

The Cell and Gene Therapy Catapult is planning to create the Manufacturing Innovation Centre in Braintree in the United Kingdom. Supported by £100 million in government funding, the project will enable mass production of a COVID-19 vaccine. An existing pharmaceutical plant has been purchased from Benchmark Holdings at a cost of £16 million. The structure's GMP infrastructure for antigen production, formulation, process development, and scale manufacturing will be repurposed and enhanced. Completion is expected in December of 2021.

Read More

DiNAQOR AG Completes Gene Therapy R&D Center

Published 7/31/2020

DiNAQOR AG completed construction in July of 2020 on a 9,687-sf R&D center in Schlieren, Switzerland. Located in the Bio-Technopark Schlieren-Zürich, the BSL-2 facility will enable DiNAQOR to fast-track the development of its human-induced pluripotent stem cells (iPSC) and engineered heart tissue platform. Accelerating the creation of next-generation genetic medicine methodologies, the project also provides sophisticated infrastructure to further optimize the company's proprietary locoregional heart perfusion approach.

Read More

Winstanley Enterprises Plans Bioscience Research Building in New Haven

Published 7/29/2020

Winstanley Enterprises is planning to build a $100 million bioscience research building in New Haven, Conn. Designed by Elkus Manfredi Architects, the 10-story, 500,000-sf facility will provide leasable laboratory and office environments for life science companies and academic institutions. Featuring a large public plaza, the project will include a conference center, a 50,000-sf business incubator, and a classroom for K-12 educational programs.

Read More

MilliporeSigma Expands Research and Testing Facilities

Published 7/23/2020

MilliporeSigma, a subsidiary of Merck, is planning to expand its existing campus in Buchs, Switzerland, with the construction of a $20 million laboratory for the company's reference materials business. Accommodating 40 employees, the three-story, 12,000-sf structure will provide analytical and R&D suites for the testing of pharmaceuticals, environmental materials, and food and beverage products.

Read More

SiO2 Expands Production Capacity for Vaccine Vials and Syringes

Published 7/18/2020

SiO2 Materials Science is investing $163 million to expand its production capacity for vaccine vials and syringes in Auburn, Ala. The company will increase the footprint of its existing facility in the Auburn Technology Park West to create a 70,000-sf manufacturing center with additional space for precision injection molding operations. A second molding plant will also be constructed nearby. 

Read More

Wake Technical Community College Constructs Biotechnology Building

Published 7/1/2020

Wake Technical Community College is constructing the $33.4 million Lilly Science and Technology Center in Morrisville, N.C. Designed by O'Brien Atkins Associates, the 66,000-sf facility will provide sophisticated classrooms and laboratories for the school's growing biotechnology programs. The three-story structure will accommodate a biopharmaceutical simulation suite, a cleanroom for training courses in aseptic processing techniques, information technology labs, and conference rooms.

Read More

Trammell Crow Constructs Fulton Labs Development

Published 6/26/2020

Trammell Crow Company will break ground in July of 2020 on Fulton Labs in Chicago. Providing wet and dry research environments, the 16-story, 423,454-sf life science facility will offer column-free and long-span layouts as well as a dedicated innovation floor for early-stage companies. Designed for maximum flexibility and scalability, the 16-story structure will integrate advanced mechanical infrastructure to support advanced R&D enterprises, with all labs meeting VC-A vibration criteria to ensure reproducible research results.

Read More

Ryvu Therapeutics Completes R&D Center for Innovative Drugs

Published 6/9/2020

Ryvu Therapeutics completed construction in June of 2020 on the R&D Center for Innovative Drugs in Krakow, Poland. Accommodating approximately 300 employees, the $20 million headquarters and research facility will enable the clinical-stage biopharmaceutical company to accelerate the development of novel small molecule therapies that address emerging targets in oncology.

Read More

Catalent Increases Bloomington Manufacturing Capacity for SARS-CoV-2 Vaccine Candidate

Published 6/4/2020

Catalent is rapidly scaling up its manufacturing capacity in Bloomington to enable production of a SARS-CoV-2 vaccine candidate that is currently being by developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. The collaboration involves joint investment from Catalent and Janssen to enable large-scale commercial manufacturing by January of 2021, with segregated cGMP production lines operating 24/7 to create approximately a billion doses.

Read More

Exyte Partners with Univercells to Create Modular Vaccine Development Facilities

Published 5/26/2020

Exyte is partnering with Univercells Technologies to create modular biomanufacturing facilities to meet the increased global demand for vaccines during the SARS-CoV-2 pandemic. Exyte’s prefabricated construction system, ExyCell, is paired with Univercells’ NevoLine biomanufacturing platform which features the scale-X™ fixed-bed bioreactor at its core.

Read More

Erlab Presents Webinar on Chemical Risks in the Laboratory

Published 5/22/2020

Erlab, a leading provider of air filtration solutions, is presenting a webinar on the mitigation of chemical risks in the laboratory at 10:00 AM BST on May 29, 2020. The one-and-a-half hour session will explore strategies for treating chemical risks at the source to enhance occupant safety and promote operational efficiency.

Visit GoToWebinar to register.

The webinar is also being offered in Spanish, Polish, French, and Maghreb French on separate days:

Read More

Medicago Builds Vaccine Manufacturing Complex in Quebec City

Published 5/20/2020

Medicago is building a 646,000-sf vaccine manufacturing complex in Quebec City, Canada. Designed by NFOE, the facility will support the production of approximately 50 million doses of recombinant quadrivalent influenza vaccine per year. The project has a construction cost of CAD$143 million and is expected to be fully operational in 2023.

Medicago is currently developing a vaccine for SARS-CoV-2 which has successfully induced a positive antibody response in mouse models. Human clinical trials are expected to begin in summer of 2020. 

Read More

Biogen Completes Biologics Manufacturing Center

Published 5/18/2020

Biogen completed construction in late spring of 2020 on a leading-edge biologics manufacturing center in Luterbach, Switzerland. Representing an investment of $1.5 billion, the modular and flexible facility leverages Biogen’s latest strategies for fed-batch cell culture technologies and protein purification processes. Offering two cell manufacturing lines, the 260,000-sf complex features two production buildings, each housing four 15,000-liter bioreactors. The campus also provides laboratories, offices, maintenance buildings, and a warehouse.

Read More